To include your compound in the COVID-19 Resource Center, submit it here.

Gossamer sets fixed share price for $230M IPO to sidestep shutdown

In a bid to keep its IPO from getting bogged down by the U.S. government shutdown, Gossamer Bio Inc. (San Diego, Calif.) plans to take advantage of a rule allowing a

Read the full 318 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers